Bank of America
ABVC icon

Bank of America’s ABVC BioPharma ABVC Stock Holding History

Bank of America’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-189
Closed -$402 – 5694
2025
Q4 		$402 Buy
189
+14
+8% +$38 ﹤0.01% 6591
2025
Q3 		$532 Buy
175
+42
+32% +$129 ﹤0.01% 7578
2025
Q2 		$296 Buy
133
+48
+56% +$65 ﹤0.01% 7771
2025
Q1 		$90 Buy
85
+4
+5% +$2 ﹤0.01% 7852
2024
Q4 		$48 Buy
81
+3
+4% +$2 ﹤0.01% 7869
2024
Q3 		$53 Sell
78
-178
-70% -$128 ﹤0.01% 7831
2024
Q2 		$198 Sell
256
-4,184
-94% -$4.3K ﹤0.01% 7564
2024
Q1 		$5.82K Buy
+4,440
New +$5.75K ﹤0.01% 6979
2023
Q1 		– Sell
-5
Closed -$32 – 7750
2022
Q4 		$32 Buy
+5
New +$37 ﹤0.01% 7883
2021
Q4 		– Sell
-49
Closed -$1K – 8161
2021
Q3 		$1K Buy
+49
New +$1.39K ﹤0.01% 7954

Other funds holding ABVC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Bank of America's ABVC Position: Q1 2026 in Review

Bank of America sold out of ABVC BioPharma (ABVC) in Q1 2026, closing a stake of 189 shares — an estimated $402 sold.

Bank of America first reported a position in ABVC in Q3 2021 and held it in 10 quarters. The position peaked at $5.82K in Q1 2024. 13 funds tracked by Wall St. Rank hold ABVC as of Q1 2026.

  • Bank of America reported no remaining ABVC BioPharma position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 189 ABVC BioPharma shares in Q1 2026, an estimated $402.
  • Bank of America first reported a position in ABVC BioPharma in Q3 2021 and held it in 10 quarters.
  • Bank of America's ABVC BioPharma position peaked at $5.82K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held ABVC BioPharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.